170 related articles for article (PubMed ID: 28913825)
21. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
22. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
23. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
De Diego EV; Lanteri-Minet M
Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
[TBL] [Abstract][Full Text] [Related]
24. Craniosacral therapy for migraine: protocol development for an exploratory controlled clinical trial.
Mann JD; Faurot KR; Wilkinson L; Curtis P; Coeytaux RR; Suchindran C; Gaylord SA
BMC Complement Altern Med; 2008 Jun; 8():28. PubMed ID: 18541041
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine.
Seng EK; Holroyd KA
Ann Behav Med; 2010 Dec; 40(3):235-47. PubMed ID: 20812037
[TBL] [Abstract][Full Text] [Related]
26. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
27. Behavioral and nonpharmacologic treatments of headache.
Lake AE
Med Clin North Am; 2001 Jul; 85(4):1055-75. PubMed ID: 11480258
[TBL] [Abstract][Full Text] [Related]
28. Predicting disability and quality of life in a community-based sample of women with migraine headache.
Kolotylo CJ; Broome ME
Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program.
Wallasch TM; Angeli A; Kropp P
Headache; 2012; 52(7):1094-105. PubMed ID: 22703374
[TBL] [Abstract][Full Text] [Related]
30. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients.
Miller S; Watkins L; Matharu M
J Headache Pain; 2016 Dec; 17(1):68. PubMed ID: 27475100
[TBL] [Abstract][Full Text] [Related]
32. Occipital Nerve Stimulation for Refractory Chronic Migraine: Results of a Long-Term Prospective Study.
Rodrigo D; Acin P; Bermejo P
Pain Physician; 2017; 20(1):E151-E159. PubMed ID: 28072807
[TBL] [Abstract][Full Text] [Related]
33. Sleep disturbance and affective comorbidity among episodic migraineurs.
Walters AB; Hamer JD; Smitherman TA
Headache; 2014 Jan; 54(1):116-24. PubMed ID: 23808359
[TBL] [Abstract][Full Text] [Related]
34. A proactive approach to migraine in primary care: a pragmatic randomized controlled trial.
Smelt AF; Blom JW; Dekker F; van den Akker ME; Knuistingh Neven A; Zitman FG; Ferrari MD; Assendelft P
CMAJ; 2012 Mar; 184(4):E224-31. PubMed ID: 22231680
[TBL] [Abstract][Full Text] [Related]
35. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
[TBL] [Abstract][Full Text] [Related]
37. Depression and anxiety: effect on the migraine-obesity relationship.
Tietjen GE; Peterlin BL; Brandes JL; Hafeez F; Hutchinson S; Martin VT; Dafer RM; Aurora SK; Stein MR; Herial NA; Utley C; White L; Khuder SA
Headache; 2007 Jun; 47(6):866-75. PubMed ID: 17578537
[TBL] [Abstract][Full Text] [Related]
38. Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.
Guerzoni S; Pellesi L; Baraldi C; Pini LA
J Headache Pain; 2015; 17():48. PubMed ID: 27146068
[TBL] [Abstract][Full Text] [Related]
39. Manual therapy for chronic migraine: a pragmatic randomised controlled trial study protocol.
Odell J; Clark C; Hunnisett A; Ahmed OH; Branney J
Chiropr Man Therap; 2019; 27():11. PubMed ID: 30962877
[TBL] [Abstract][Full Text] [Related]
40. Living with chronic migraine: a qualitative study on female patients' perspectives from a specialised headache clinic in Spain.
Palacios-Ceña D; Neira-Martín B; Silva-Hernández L; Mayo-Canalejo D; Florencio LL; Fernández-de-Las-Peñas C; García-Moreno H; García-Azorín D; Cuadrado ML
BMJ Open; 2017 Aug; 7(8):e017851. PubMed ID: 28827275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
